Mozavaptan , ≥99% , 137975-06-5
CAS NO.：137975-06-5
Empirical Formula: C27H29N3O2
Molecular Weight: 427.54
MDL number: MFCD00908918
EINECS: 1312995-182-4
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB486.72 | In Stock |
|
| 50MG | RMB1506.40 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 213 - 217°C |
| Boiling point: | 543.0±50.0 °C(Predicted) |
| Density | 1.21±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 13.04±0.70(Predicted) |
| color | White to Off-White |
Description and Uses
Mozavaptan is an oral vasopressin V2 antagonist that has been launched in Japan for inappropriate antidiuretic hormone secretion syndrome (IADHS), an affliction manifesting as hyponatremia. It joins another nonpeptidic benzazepine, conivaptan, which corrects sodium and water imbalance by blocking the renal V2 receptor resulting in enhanced diuresis, thereby effectively increasing serum sodium concentration. While conivaptan inhibits both V1 and V2 receptors, mozavaptan is significantly more selective for V2 (IC50 of 14nM vs. 1.2 mM for V1).
Mozavaptan is a vasopressin-receptor antagonist. It is used in the treatment of congestive heart failure and hyponatremia.
